vimarsana.com

Page 10 - கீழ் மருந்து செலவுகள் இப்போது நாடகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

88 Percent Of Older Adults Want Medicare To Negotiate Drug Prices According to New Survey by The Senior Citizens League

88 Percent Of Older Adults Want Medicare To Negotiate Drug Prices According to New Survey by The Senior Citizens League Font : A-A+ Of the 1,234 participants surveyed, 88 percent support tying prescription drug prices to what other industrialized countries, such as Great Britain, Canada and Japan, pay for the same drug. WASHINGTON, May 25, 2021 /PRNewswire-PRWeb/  Older Americans overwhelmingly support legislation that would allow Medicare to negotiate prescription drug prices, according to a new survey by The Senior Citizens League (TSCL). The online survey, which had over 1,234 participants, found that 88 percent support tying prescription drug prices to what other industrialized countries, such as Great Britain, Canada and Japan, pay for the same drug.

Swiss pharma industry fights lower drug prices in the US

Swiss pharma industry fights lower drug prices in the US The American subsidiaries of Swiss drug giants, Roche and Novartis, have actively participated in the lobbying of US Congress members over the proposal to lower drug prices in the US. Copyright 2017 The Associated Press. All Rights Reserved. A proposed law currently under discussion in the United States Congress aims to lower prescription drug prices. But Big Pharma, including Swiss giants Roche and Novartis, are pulling out all the stops to lobby against the measure. This content was published on May 24, 2021 - 10:11 May 24, 2021 - 10:11 Alexis Rapin, Montréal The issue often sparks heated debate across the Atlantic. The cost of prescription drugs in the US is among the highest in the world, with many Americans regularly forced to bleed themselves dry just to pay their pharmaceutical bills. Written in 2019 and dusted off last April, draft legislation to reform the law is currently being discussed by Congress. It’s a m

Latest Articles

Latest Articles
freerepublic.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freerepublic.com Daily Mail and Mail on Sunday newspapers.

Congress takes aim again at pharmaceutical giant over patent-stacking for brand-name drugs

Print this article House lawmakers put AbbVie pharmaceuticals CEO Richard Gonzalez in the hot seat this week over concerns that the drugmaker behind top-selling medications exploited the U.S. patent system to stave off competition. The Oversight Committee hearing was Congress’s latest effort to crack down on pharmaceutical industry price-gouging. “Our investigation has revealed that the justifications the pharmaceutical industry offers for why they need to raise prices simply do not hold water,” New York Democrat and House Oversight Committee Chairwoman Carolyn Maloney said in the May 18 hearing. “Our investigation also uncovered evidence that AbbVie … engaged in anti-competitive practices to extend its monopoly pricing.”

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.